High Court Approves MSD’s Successful Acquisition of Verona
MSD, the tradename of Merck & Co., will acquire Verona Pharma for $107 per American Depositary Share in a...
AI Drug Discovery AstraZeneca BIO-Europe Spring 2026 biopharma M&A biopharma strategy biotech funding biotech strategy business development cancer immunotherapy China Biotech CNS Pipeline Strategy competitive intelligence Disease-Modifying Therapy Drug Pricing Strategy eClinical Tech News Eli Lilly Emerging Markets FDA Approval FDA Priority Review HER2 Oncology immuno-oncology immunology licensing deals Lifecycle Management Market Access Medtronic MSS colorectal cancer Novo Nordisk Obesity/GLP-1 Obesity Drug Market Obesity Market Oncology Pipeline Patent Cliff Priority Review Voucher pulmonary hypertension Rare Disease Regeneron respiratory biologics Roche Sanofi series A funding Teva Pharmaceuticals Type 1 Diabetes Type 2 Diabetes venture capital
No videos found.
MSD, the tradename of Merck & Co., will acquire Verona Pharma for $107 per American Depositary Share in a...
Equillium has restructured its leadership and governance while exiting a legacy collaboration to concentrate resources on a single internal...
Profusa has expanded its European footprint through a collaboration with Yann Gouëffic, professor of vascular surgery at Groupe Hospitalier...
Kraig Biocraft Laboratories has announced commercial-scale production of spider silk using genetically engineered silkworms, converting a long-celebrated biomaterial into...
HUTCHMED will take a broad slate of oncology data to ESMO 2025, headlined by the FRUSICA-2 registration study of...
Xilio Therapeutics will unveil new clinical and preclinical data at the Society for Immunotherapy of Cancer’s annual meeting on...
CMS has activated a permanent HCPCS J-code, J3402, for Mesoblast’s Ryoncil (remestemcel‑l‑rknd), effective October 1, 2025. The code creates...
Rockcliffe Labs has acquired a controlling interest in Algae-C for cash, making the Canadian algae-based discovery company a majority-owned...
Rockcliffe Labs has acquired a controlling interest in Algae-C for cash, making Algae-C a majority-owned subsidiary with its legacy...
Achieve Life Sciences has granted stock options covering 161,000 shares to five new employees under its 2024 equity inducement...
